Identification of a candidate therapeutic autophagy-inducing peptide

Nature

Volumn 494, Issue 7436, 2013, Pages 201-206

  Shoji Kawata, Sanae ^a,b   Sumpter, Rhea ^a,b   Leveno, Matthew ^a,b   Campbell, Grant R ^c,d   Zou, Zhongju ^a,b,e   Kinch, Lisa ^a,e   Wilkins, Angela D ^f   Sun, Qihua ^a,b   Pallauf, Kathrin ^a   MacDuff, Donna ^g   Huerta, Carlos ^a,n   Virgin, Herbert W ^g   Bernd Helms, J ^h   Eerland, Ruud ^h   Tooze, Sharon A ⁱ   Xavier, Ramnik ^j,k   Lenschow, Deborah J ^g   Yamamoto, Ai ^l   King, David ^m   Lichtarge, Olivier ^f   Grishin, Nick V ^a,e   Spector, Stephen A ^c,d   Kaloyanova, Dora V ^h   Levine, Beth ^a,b,e   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UTRECHT UNIVERSITY   (Netherlands)

ⁱ IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^l NONE   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ Reata Pharmaceuticals Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; GAPR 1 PROTEIN; POLYGLUTAMINE; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AGING; BIOTECHNOLOGY; DISEASE TREATMENT; IDENTIFICATION METHOD; PATHOGEN; PEPTIDE; PROTEIN; PUBLIC HEALTH; RODENT; VIRAL DISEASE; VIRULENCE; VIRUS;

ARTICLE; CHIKUNGUNYA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEST NILE FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHIKUNGUNYA VIRUS; HELA CELLS; HIV-1; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; WEST NILE VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; WEST NILE VIRUS;

EID: 84873709314     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11866     Document Type: Article

References (44)

1. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42 (2008).
2. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075 (2008).
3. Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nature Rev. Drug Discov. 11, 709-730 (2012).
4. Kihara, A., Kabeya, Y., Ohsumi, Y. & Yoshimori, T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2, 330-335 (2001).
5. Kyei, G. B. et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255-268 (2009).
6. Furuya, N., Yu, J., Byfield, M., Pattingre, S. & Levine, B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1, 46-52 (2005).
7. Huang, W. et al. Crystal structure and biochemical analyses reveal Beclin 1 as a novel membrane binding protein. Cell Res. 22, 473-489 (2012).
8. Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin Nature 402, 672-676 (1999).
9. Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313-326 (2010).
10. van den Berg, A. & Dowdy, S. F. Protein transduction domain delivery of therapeutic macromolecules. Curr. Opin. Biotechnol. 22, 888-893 (2011).
11. Bayer, P. et al. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247, 529-535 (1995).
12. Lee, J. S. et al. FLIP-mediated autophagy regulation in cell death control. NatureCell Biol. 11, 1355-1362 (2009).
13. Orvedahl, A. O. et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 7, 115-127 (2010).
14. Eberle, H. B. et al. Identification and characterization of a novel human plant pathogenesis-related protein that localizes to lipid-enriched microdomains in the Golgi complex. J. Cell Sci. 115, 827-838 (2002).
15. Polson, H. E. et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 6, 506-522 (2010).
16. Harris, H. & Rubinsztein, D. C. Control of autophagy as a therapy for neurodegenerative disease. Nature Rev. Neurol. 8, 108-117 (2012).
17. Yamamoto, A., Cremona, M. L. & Rothman, J. E. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol. 172, 719-731 (2006).
18. Yoshikawa, Y. et al. Listeriamonocytogenes ActA-mediated escape fromautophagic recognition. Nature Cell Biol. 11, 1233-1240 (2009).
19. Zhao, Z. et al. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4, 458-469 (2008).
20. Campbell, G. R. & Spector, S. A. Hormonally active vitamin D3 (1a,25-dihydroxycholecalciferol) triggers autophagy inhumanmacrophages that inhibits HIV-1 infection. J. Biol. Chem. 286, 18890-18902 (2011).
21. Campbell, G. R.& Spector, S. A. VitaminD inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 8, e1002689 (2012).
22. Mizushima, N., Yamamoto, A.,Matsui, M., Yoshimori, T.&Ohsumi, Y. In vivo analysis of autophagy in response tonutrient starvation using transgenic mice expressinga fluorescent autophagosome marker. Mol. Biol. Cell 15, 1101-1111 (2004).
23. Fischer, P. M. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review. Curr. Protein Pept. Sci. 4, 339-356 (2003).
24. Couderc, T. et al.Amousemodel for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 4, e29 (2008).
25. Johnson, R. T. Acute encephalitis. Clin. Infect. Dis. 23, 219-226 (1996).
26. Griffin, D. E. Emergence and re-emergence of viral diseases of the central nervous system. Prog. Neurobiol. 91, 95-101 (2010).
27. Lauer, P., Chow, M. Y., Loessner, M. J., Portnoy, D. A. & Calendar, R. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184, 4177-4186 (2002).
28. Sato, M. et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 66, 2116-2128 (2006).
29. Pattingre, S. et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939 (2005).
30. O'Neill, E. et al. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J. Virol. 80, 1311-1320 (2006).
31. Kabeya, Y. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720-5728 (2000).
32. Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandemfluorescent-tagged LC3. Autophagy 3, 452-460 (2007).
33. Thoreen, C. C. et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions ofmTORC1. J. Biol. Chem. 284, 8023-8032 (2009).
34. Balch, W. E., Dunphy, W. G., Braell, W. A. & Rothman, J. E. Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine. Cell 39, 405-416 (1984).
35. Vogels, M. W. et al. Quantitative proteomic identification of host factors involved in the Salmonella typhimuriuminfection cycle. Proteomics 11, 4477-4491 (2011).
36. Bréhin, A. C. et al. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virology 371, 185-195 (2008).
37. Mihalek, I., Res, I. & Lichtarge, O. A family of evolution-entropy hybrid methods for ranking protein residues by importance. J. Mol. Biol. 336, 1265-1282 (2004).
38. Bailey, C. K., Andriola, I. F., Kampinga, H. H. & Merry, D. E. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11, 515-523 (2002).
39. Taylor, R. M., Hurlbut, H. S., Work, T. H., Kingston, J. R. & Frothingham, T. E. Sindbis virus: a newly recognized arthropod-transmitted virus. Am. J. Trop. Med. Hyg. 4, 844-862 (1955).
40. Keller, B. C. et al. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80, 9424-9434 (2006).
41. Weiner, L. P., Cole, G. A. & Nathanson, N. Experimental encephalitis following peripheral inoculation ofWest Nile virus inmice of different ages. J. Hyg. (Lond.) 68, 435-446 (1970).
42. Schuffenecker, I. et al.Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 3, e263 (2006).
43. Gartner, S. et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219 (1986).
44. Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809-1820 (2003).